Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
DMAQ Stock Forecast 2025-2026
$0.31
Current Price
$12.90M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to DMAQ Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
DMAQ Price Momentum
+24.0%
1 Week Change
-16.2%
1 Month Change
-81.1%
1 Year Change
-55.1%
Year-to-Date Change
-82.3%
From 52W High of $1.75
+41.6%
From 52W Low of $0.22
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Deep Medicine Acquisition (DMAQ) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on DMAQ and similar high-potential opportunities.
Latest DMAQ Stock Price Targets & Analyst Predictions
DMAQ has shown a year-to-date change of -55.1% and a 1-year change of -81.1%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for DMAQ. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
DMAQ Analyst Ratings
0
Buy
0
Hold
0
Sell
DMAQ Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.31
Latest DMAQ Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for DMAQ.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Deep Medicine Acquisition Corp. (DMAQ) Competitors
The following stocks are similar to Deep Medicine Acquisition based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Deep Medicine Acquisition Corp. (DMAQ) Financial Data
Deep Medicine Acquisition Corp. has a market capitalization of $12.90M with a P/E ratio of 213.0x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -15.7%.
Valuation Metrics
Market Cap
$12.90M
Enterprise Value
$14.69M
P/E Ratio
213.0x
PEG Ratio
-5.3x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+26.5%
Current Ratio
2.0x
Debt/Equity
-2.4x
ROE
-15.7%
ROA
-1.8%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Deep Medicine Acquisition Corp. (DMAQ) Business Model
About Deep Medicine Acquisition Corp.
What They Do
Specializes in healthcare industry mergers and acquisitions.
Business Model
The company aims to generate revenue by merging with or acquiring businesses in the healthcare sector. It does not currently have significant operations and operates as a blank check company, focusing on identifying potential targets for business combination.
Additional Information
Incorporated in 2020 and based in New York, Deep Medicine Acquisition Corp. functions as a subsidiary of Bright Vision Sponsor LLC, positioning itself strategically within the healthcare market.
Deep Medicine Acquisition Corp. (DMAQ) Latest News & Analysis
Latest News
Quick Summary
TruGolf, Inc. has completed its business combination with Deep Medicine Acquisition Corp., becoming publicly traded as TruGolf Holdings, Inc. on Nasdaq under the ticker TRUG.
Why It Matters
The closure of the business combination elevates TruGolf to public company status, potentially enhancing its capital access and market visibility, which could influence investor interest and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
TruGolf, Inc. and Deep Medicine Acquisition Corp. announced SEC approval of their business combination, with a special stockholder meeting scheduled for approval.
Why It Matters
TruGolf's merger with DMAQ could enhance its market presence and access to capital, potentially increasing value for shareholders and reshaping the competitive landscape in golf technology.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Deep Medicine Acquisition Corp. (DMAQ) filed a registration statement with the SEC for its proposed business combination with TruGolf, announced on March 31, 2023.
Why It Matters
The filing of the registration statement signals progress in the merger between DMAQ and TruGolf, potentially increasing investor interest and affecting stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Deep Medicine Acquisition (NASDAQ: DMAQ) stock is rising following an update on its merger plans with TruGolf as part of its business combination.
Why It Matters
Deep Medicine Acquisition's stock rise signals investor confidence in the upcoming merger with TruGolf, potentially enhancing future growth and market position.
Source: InvestorPlace
Market Sentiment:
Positive
Deep Medicine Acquisition Corp. and TruGolf, Inc. Announce the Execution of a Definitive Merger Agreement
2 years ago
Quick Summary
TruGolf, Inc. plans to go public to enhance its software business and expand the manufacturing and sales of its golf simulator technology domestically and internationally.
Why It Matters
TruGolf's IPO signals growth potential in the golf simulator market, attracting investor interest in its software and manufacturing expansion, which may enhance revenue and market presence.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Deep Medicine Acquisition Corp. (DMAQ) will transfer its listing from the Nasdaq Global Market to the Nasdaq Capital Market, effective February 17, 2023, with no impact on trading.
Why It Matters
The transfer to the Nasdaq Capital Market may indicate financial instability or lower growth expectations, potentially affecting investor confidence and stock performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About DMAQ Stock
What is Deep Medicine Acquisition Corp.'s (DMAQ) stock forecast for 2025?
Analyst forecasts for Deep Medicine Acquisition Corp. (DMAQ) are not currently available. The stock is trading at $0.31.
Is DMAQ stock a good investment in 2025?
Analyst ratings for DMAQ are not currently available. The stock is currently trading at $0.31. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for DMAQ stock?
Price predictions from Wall Street analysts for DMAQ are not currently available. The stock is trading at $0.31.
What is Deep Medicine Acquisition Corp.'s business model?
The company aims to generate revenue by merging with or acquiring businesses in the healthcare sector. It does not currently have significant operations and operates as a blank check company, focusing on identifying potential targets for business combination.
What is the highest forecasted price for DMAQ Deep Medicine Acquisition Corp.?
Price targets from Wall Street analysts for DMAQ are not currently available. The stock is trading at $0.31.
What is the lowest forecasted price for DMAQ Deep Medicine Acquisition Corp.?
Price targets from Wall Street analysts for DMAQ are not currently available. The stock is trading at $0.31.
What is the overall DMAQ consensus from analysts for Deep Medicine Acquisition Corp.?
Analyst ratings for DMAQ are not currently available. The stock is trading at $0.31.
How accurate are DMAQ stock price projections?
Stock price projections, including those for Deep Medicine Acquisition Corp., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 2:15 PM UTC